Showing 1 - 5 results of 5 for search 'Linda Duska', query time: 0.03s Refine Results
  1. 1
    Intraosseous hibernoma in a patient with vaginal cancer: Case report with radiologic and pathologic correlation

    Intraosseous hibernoma in a patient with vaginal cancer: Case report with radiologic and pathologic correlation by Ashley Zhang, Emily Nesbit, Sarah Erickson, Linda Duska, Michael Crawford, Kara Romano

    Published 2024-12-01
    Get full text
    Article
  2. 2
    Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.

    Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance. by J Stuart Ferriss, Youngchul Kim, Linda Duska, Michael Birrer, Douglas A Levine, Christopher Moskaluk, Dan Theodorescu, Jae K Lee

    Published 2012-01-01
    Get full text
    Article
  3. 3
    531 A Phase 1b multi-tumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors: results of the triple-negative breast cancer, ovarian cancer, and endometrial cancer cohorts

    531 A Phase 1b multi-tumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors: results of the triple-negative breast cancer, ovarian cancer, and endometrial ca... by Vivek Subbiah, Capucine Baldini, Kristen Spencer, Luis Manso, Armando Santoro, Sandip Patel, Joaquina Baranda, Ira Winer, Akhila Wimalasingham, Linda Duska, Polina Khrizman, Griet Van Lancker, Lana Andrianova, Sumandeep Atwal, Keerti Sharma

    Published 2021-11-01
    Article
  4. 4
    Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

    Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable... by Lucy Gilbert, Ana Oaknin, Prafull Ghatage, Rebecca Kristeleit, Wei Guo, Sharad Ghamande, Valentina Boni, Jubilee Brown, Xinwei Han, Vanessa Samouëlian, Ellie Im, Renaud Sabatier, Anna V Tinker, David M O’malley, Bhavana Pothuri, Cara Mathews, Jennifer Veneris, Tao Duan, Linda Duska, Joshua Press, Charles Leath III, Sybil Zildjian

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer

    Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer by John Wright, Stephanie Lheureux, Ilaria Colombo, Ramy Gadalla, Pamela S Ohashi, Xuan Li, Lisa Wang, Matthew S Block, David G Brooks, Andrea Jewell, Carolyn McCourt, Eugenia Girda, Sarah Temkin, Gini F Fleming, Linda Duska, Daniela E Matei, Panagiotis A Konstantinopoulos, Ben X Wang, Stephanie L Gaillard, Michael McHale, Floor J Backes, Theresa L Werner, Siobhan Kehoe, Rachel Wildman, Shirin Soleimani, Scott Lien, Trevor Pugh

    Published 2022-03-01
    Get full text
    Article

Search Tools: